London's Pulse: Medical Officer of Health reports 1848-1972

View report page

City of London 1925

[Report of the Medical Officer of Health for London, City of ]

This page requires JavaScript

Statement showing the services rendered at the Treatment Centre during the year, classified according to the areas in which the patients resided.

Name of County or County Borough (or Country in the case of persons residing elsewhere than in England and Wales) to be inserted in these headings.London.Essex.Herts.Surrey.Kent.Bucks.Leicester.Total.
A. Number of cases from each area dealt with during the year for the first time and found to be suffering from:—
Syphilis1443l....l....l................150
Soft chancre................................................
Gonorrhœa1981....l....ll................202
Conditions other than venereal48................2....................50
Total3904lll32................402
B. Total number of attendances of all patients residing in each area10,5058812251................10,541
C. Aggregate number of "Inpatient days" of all patients residing in each area20........................................20
D. Number of doses of Arsenobenzol compounds given in the:—
1. Out-patient Clinic1,7741....7............................1,782
2. In-patient Dept. to patients residing in each area.................................................
E. Give the names of Arsenobenzol compounds used in the treatment of syphilis and the usual initial and final doses.Neo.- Salvarsan. Nov-Arsenobillon. Neo.-Kharsivan Stabilarsan. Silver Salvarsan. Sulfarsenol. Initial dose, Male, .6 to .9. Female, .6 to .75.
F. State the amount and kind of treatment usually administered to a case of Syphilis of each of the types usually dealt with at the Treatment Centre.Usual course, 8 to 10 injections of Arsenical compounds, with 10 to 20 Mercury injections. 3 to 4 courses in the 1st yr., 2 to 3 courses in the 2nd yr., according to W.R. Hvd., Per. c Pot. Iod. between. 15 injections Iodine-Bismuth-Quinine, Trépol, Neo-Trépol, Muthanol, Luatol, Contralucsin, Mercurosal, Collosal Iodine in conjunction with or without Arsenical compounds.
G. State the nature of tests applied in deciding as to discharge of patients referred to in Item 5 on previous page.
Gonorrhœa—Male. Urethroscopy. Cessation of treatment Alcohol, Films and cultures from urethal discharge, and from threads, if any, and from prostatic and vesicular secretions on 3 occasions at weekly intervals. Female. Films and sometimes cultures from cervix ant urethra (and from Bartholin's glands if necessary) after at least 3 successive menstrual periods

Date 20/1/26. (Signed) KENNETH M. WALKER,
Medical Officer of the Treatment Centre.